ORLANDO — About 20% of a cohort of patients with aggressive relapsed or refractory non-Hodgkin lymphoma experienced complete response to treatment with the investigational agent mosunetuzumab, according to updated data from a phase 1/phase 1b dose-escalation and dose-expansion study presented during the plenary session of ASH Annual Meeting and Exposition.Mosunetuzumab (Genentech) also
KOLOA, Hawaii — Start with the patient’s chief complaint when making a differential diagnosis in uveitis, a retina specialist said at Retina 2025. “You see…
KOLOA, Hawaii — Proper credentialing, emergency protocols and preoperative discussion with your anesthesia provider all can help practices avoid medical negligence claims, according to a…
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Amina Malik, MD, discusses dangerous disease mimics in neuro-ophthalmology. “You may think it’s…
Recent changes to a heart transplant allocation policy improved waitlist outcomes for children born with heart defects and adults with cardiomyopathy, but not in children…
KOLOA, Hawaii — The ophthalmology community must collaborate to create guidelines for diligent AI use in health care to avoid malpractice, according to a presenter…
KOLOA, Hawaii — The success of a Jones tube procedure relies on the surgeon’s ability to deliver clear instructions to the patient, according to a…
KOLOA, Hawaii — The three primary goals of upper blepharoplasty are ensuring patient happiness, obtaining an aesthetic result and avoiding complications, according to a speaker…
From 2002 to 2021, the incidence rate of alcohol-associated hepatitis “more than doubled” among adolescents and young adults in Ontario, Canada, with the highest uptick…
Healio and Mathematica, a research and data analytics consultancy, have partnered to launch Healio PRICE Compass, a pricing transparency tool developed by Mathematica that will…
